| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |